论文部分内容阅读
目的比较多次皮下注射法(MSII)、持续静脉泵注法(CSII)注射胰岛素治疗糖尿病的临床疗效及相关护理风险。方法选取溧阳市人民医院2015年1月—2016年10月收治的2型糖尿病住院患者65例,根据随机数字表法将所有患者分为CSII组(n=33)和MSII组(n=32)。患者入院后均给予注射重组人胰岛素治疗,CSII组患者采用持续静脉泵注方式,MSII组患者采取多次皮下注射方式。比较两组患者血糖达标时间,观察患者护理风险事件发生情况。结果 CSII组患者血糖达标时间短于MSII组(P<0.05)。CSII组患者护理风险事件发生率低于MSII组(P<0.05)。结论采用CSII注射胰岛素在2型糖尿病患者中的应用效果优于MSII,可有效降低患者血糖水平,缩短治疗时间,且护理风险低。
Objective To compare the clinical effects of multiple subcutaneous injections (MSII) and continuous intravenous infusion (CSII) insulin in the treatment of diabetes and the related nursing risks. Methods Sixty-five inpatients with type 2 diabetes mellitus were selected from Liyang People’s Hospital from January 2015 to October 2016. All patients were divided into CSII group (n = 33) and MSII group (n = 32) according to random number table method . Patients were admitted to hospital after injection of recombinant human insulin therapy, patients in CSII group by continuous intravenous infusion, MSII patients taking multiple subcutaneous injection. Blood glucose compliance time was compared between the two groups to observe the occurrence of patient care risk events. Results The blood glucose level of CSII group was shorter than MSII group (P <0.05). The incidence of nursing risk events in CSII group was lower than that in MSII group (P <0.05). Conclusion The application of CSII insulin in patients with type 2 diabetes mellitus is better than MSII, which can effectively reduce the blood sugar level and shorten the treatment time, and the nursing risk is low.